My issue is the examples in the article are also extremely limited. These are "Kickstarter"-type crowdfunding ventures. Immunity Project is backed by YC, and the Perlstein Lab is for all intents and purposes acting like a regular biotech startup. Those are both pretty narrow opportunity bands.